ID1 and hepatocellular carcinoma: Based on the microarray data, we observed a decrease in both ID1 mRNA and protein levels in human HCC cells upon treatment with usenamine A. Furthermore, as ID1 is known to undergo degradation through the ubiquitin–proteasome pathway, we investigated whether usenamine A affected ID1 protein degradation.